EZH2 dysregulation: Potential biomarkers predicting prognosis and guiding treatment choice in acute myeloid leukaemia

Accumulating studies have proved EZH2 dysregulation mediated by mutation and expression in diverse human cancers including AML. However, the expression pattern of EZH2 remains controversial in acute myeloid leukaemia (AML). EZH1/2 expression and mutation were analysed in 200 patients with AML. EZH2...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Ming‐qiang, Zhang, Ting‐juan, Xu, Zi‐jun, Gu, Yu, Ma, Ji‐chun, Zhang, Wei, Wen, Xiang‐mei, Lin, Jiang, Qian, Jun, Zhou, Jing‐dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991666/
https://www.ncbi.nlm.nih.gov/pubmed/31794134
http://dx.doi.org/10.1111/jcmm.14855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991666/
https://www.ncbi.nlm.nih.gov/pubmed/31794134
http://dx.doi.org/10.1111/jcmm.14855

Ejemplares similares